Your browser doesn't support javascript.
loading
A phase I/II study of S-1 and irinotecan (IRIS) combined with cetuximab in patients with RAS wild-type metastatic colorectal cancer (KSCC1401).
Samura, Hironori; Oki, Eiji; Okumura, Hiroshi; Yoshida, Takefumi; Kai, Seiichiro; Kobayashi, Kazuma; Kinjo, Tatsuya; Mori, Shinichiro; Tohyama, Tetsuo; Ohgaki, Kippei; Kawanaka, Hirofumi; Makiyama, Akitaka; Ureshino, Norio; Kotaka, Masahito; Shimose, Takayuki; Ando, Koji; Saeki, Hiroshi; Baba, Hideo; Maehara, Yoshihiko; Mori, Masaki.
Afiliação
  • Samura H; Gastrointestinal Disease Center, Urazoe General Hospital, Okinawa, Japan.
  • Oki E; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. okieiji@surg2.med.kyushu-u.ac.jp.
  • Okumura H; Department of Surgery, Kagoshima Koseiren Hospital, Kagoshima, Japan.
  • Yoshida T; Department of Surgery, Social Insurance Tagawa Hospital, Fukuoka, Japan.
  • Kai S; Department of Surgery, Nakatsu Municipal Hospital, Oita, Japan.
  • Kobayashi K; Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Kinjo T; Division of Digestive and General Surgery, University of the Ryukyu Faculty of Medicine, Okinawa, Japan.
  • Mori S; Department of Digestive Surgery, Breast and Thyroid Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
  • Tohyama T; Department of Surgery, Nakagami Hospital, Okinawa, Japan.
  • Ohgaki K; Department of Surgery, Kyushu Central Hospital of the Mutual Aid Association of Public School Teachers, Fukuoka, Japan.
  • Kawanaka H; Clinical Research Institute and Department of Surgery, National Hospital Organization Beppu Medical Center, Oita, Japan.
  • Makiyama A; Department of Hematology/Oncology, Japan Community Healthcare Organization Kyushu Hospital, Fukuoka, Japan.
  • Ureshino N; Cancer Center, Gifu University Hospital, Gifu, Japan.
  • Kotaka M; Department of Medical Oncology, Saga-Ken Medical Center Koseikan, Saga, Japan.
  • Shimose T; Gastrointestinal Cancer Center, Sano Hospital, Hyogo, Japan.
  • Ando K; Clinical Research Support Center Kyushu, Fukuoka, Japan.
  • Saeki H; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
  • Baba H; Department of General Surgical Science Graduate School of Medicine, Gunma University, Gunma, Japan.
  • Maehara Y; Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Mori M; Department of Surgery, Kyushu Central Hospital of the Mutual Aid Association of Public School Teachers, Fukuoka, Japan.
Cancer Chemother Pharmacol ; 86(2): 285-294, 2020 08.
Article em En | MEDLINE | ID: mdl-32734398
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas ras / Neoplasias Hepáticas / Mutação Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas ras / Neoplasias Hepáticas / Mutação Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article